These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 7954916)
21. Semi-solid dosage form of clonazepam for rapid oral mucosal absorption. Sakata O; Machida Y; Onishi H Drug Dev Ind Pharm; 2011 Jul; 37(7):809-14. PubMed ID: 21247373 [TBL] [Abstract][Full Text] [Related]
22. Phenytoin sodium microcapsules: bench scale formulation, process characterization and release kinetics. Yazici E; Oner L; Kaş HS; Hincal AA Pharm Dev Technol; 1996 Jul; 1(2):175-83. PubMed ID: 9552344 [TBL] [Abstract][Full Text] [Related]
23. Mechanism of nanoparticle formation from ternary coground phenytoin and its derivatives. Moribe K; Ogino A; Kumamoto T; Ishikawa T; Limwikrant W; Higashi K; Yamamoto K J Pharm Sci; 2012 Sep; 101(9):3413-24. PubMed ID: 22487958 [TBL] [Abstract][Full Text] [Related]
24. High-throughput study of phenytoin solid dispersions: formulation using an automated solvent casting method, dissolution testing, and scaling-up. Barillaro V; Pescarmona PP; Van Speybroeck M; Thi TD; Van Humbeeck J; Vermant J; Augustijns P; Martens JA; Van Den Mooter G J Comb Chem; 2008; 10(5):637-43. PubMed ID: 18627202 [TBL] [Abstract][Full Text] [Related]
25. Naringenin-loaded solid lipid nanoparticles: preparation, controlled delivery, cellular uptake, and pulmonary pharmacokinetics. Ji P; Yu T; Liu Y; Jiang J; Xu J; Zhao Y; Hao Y; Qiu Y; Zhao W; Wu C Drug Des Devel Ther; 2016; 10():911-25. PubMed ID: 27041995 [TBL] [Abstract][Full Text] [Related]
26. Topical phenytoin nanostructured lipid carriers: design and development. Motawea A; Borg T; Abd El-Gawad AEH Drug Dev Ind Pharm; 2018 Jan; 44(1):144-157. PubMed ID: 28956451 [TBL] [Abstract][Full Text] [Related]
27. A comparative bioavailability of 2 oral solid phenytoin dosage forms. Naik D; Morton DJ Cent Afr J Med; 1989 Apr; 35(4):384-8. PubMed ID: 2605620 [TBL] [Abstract][Full Text] [Related]
28. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus. Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257 [TBL] [Abstract][Full Text] [Related]
29. Individual variation in daily dosage requirements for phenytoin sodium in patients with epilepsy. Barot MH; Grant RH; Maheendran KK; Mawer GE; Woodcock BG Br J Clin Pharmacol; 1978 Sep; 6(3):267-71. PubMed ID: 687505 [TBL] [Abstract][Full Text] [Related]
30. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats. Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980 [TBL] [Abstract][Full Text] [Related]
31. In-vitro studies of diclofenac sodium controlled-release from biopolymeric hydrophilic matrices. Bravo SA; Lamas MC; Salamón CJ J Pharm Pharm Sci; 2002; 5(3):213-9. PubMed ID: 12553888 [TBL] [Abstract][Full Text] [Related]
32. In vitro analysis of the release of incorporated agents from sodium caseinate microspheres. Heelan BA; Corrigan OI J Microencapsul; 1997; 14(1):63-78. PubMed ID: 8994076 [TBL] [Abstract][Full Text] [Related]
33. Improved oral absorption and chemical stability of everolimus via preparation of solid dispersion using solvent wetting technique. Jang SW; Kang MJ Int J Pharm; 2014 Oct; 473(1-2):187-93. PubMed ID: 25003829 [TBL] [Abstract][Full Text] [Related]
34. Reconstituted spray-dried phenytoin-loaded nanocapsules improve the in vivo phenytoin anticonvulsant effect and the survival time in mice. de Oliveira EG; Cardoso AM; Paese K; Coradini K; de Oliveira CV; Pohlmann AR; Oliveira MS; Guterres SS; Beck RCR Int J Pharm; 2018 Nov; 551(1-2):121-132. PubMed ID: 30218826 [TBL] [Abstract][Full Text] [Related]
35. Absorption characteristics of three phenytoin sodium products after administration of oral loading doses. Goff DA; Spunt AL; Jung D; Bellur SN; Fischer JH Clin Pharm; 1984; 3(6):634-8. PubMed ID: 6509876 [TBL] [Abstract][Full Text] [Related]
36. Production of dosage forms for oral drug delivery by laminar extrusion of wet masses. Müllers KC; Wahl MA; Pinto JF Eur J Pharm Biopharm; 2013 Aug; 84(3):626-32. PubMed ID: 23403012 [TBL] [Abstract][Full Text] [Related]
37. Effects of hydrolysis on solid-state relaxation and stickiness behavior of sodium caseinate-lactose powders. Mounsey JS; Hogan SA; Murray BA; O'Callaghan DJ J Dairy Sci; 2012 May; 95(5):2270-81. PubMed ID: 22541456 [TBL] [Abstract][Full Text] [Related]
39. Optimization of caseinate-coated simvastatin-zein nanoparticles: improved bioavailability and modified release characteristics. Ahmed OA; Hosny KM; Al-Sawahli MM; Fahmy UA Drug Des Devel Ther; 2015; 9():655-62. PubMed ID: 25670883 [TBL] [Abstract][Full Text] [Related]
40. Development of clinical dosage forms for a poorly water-soluble drug II: formulation and characterization of a novel solid microemulsion preconcentrate system for oral delivery of a poorly water-soluble drug. Li P; Hynes SR; Haefele TF; Pudipeddi M; Royce AE; Serajuddin AT J Pharm Sci; 2009 May; 98(5):1750-64. PubMed ID: 18781639 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]